As indicated by the World Health Organization, the number of surgeries performed across the globe has increased and this trend is projected to continue due to increasing prevalence of chronic diseases, healthcare expenditure, and technological advancements. Inhalation anesthetics offer shorter induction and recovery time with better efficiency. Also, Inhalation anesthetics in conjugation with intravenous and other anesthetic agents offer better anesthetic effect during surgical procedures. These factors are anticipated to drive the inhalation anesthetics market during the forecasted time frame. Further, growing investment in healthcare infrastructure, development in emerging economies and increasing adoption of universal health coverage will spur the business growth.
The global inhalation anesthetics market has been segmented based on product, end-user, and geography. On basis of product, the market has been segmented into volatile liquid agents and gaseous agents. The volatile liquid agents segment is sub-segmented into sevoflurane, desoflurane, isoflurane, and others. The gaseous agents market is also divided into nitrous oxide, xenon and others. A significant share of the global market is held by the gaseous agents owing to usage as a conjugate catalyst in other anesthetic agents such as injectable and oral. Based on user type the global market has been segmented into hospitals, ambulatory surgical centers, and others.
The global Inhalation Anesthetics Market has been segmented in terms of region into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The well-established healthcare infrastructure and advancement in technologies have contributed North America to hold a significant share of the global market. Furthermore, the presence of associations that facilitate in maintaining the standards of anesthesiology will propel the industry growth in the country. The improvement in healthcare infrastructure and increase in the number of surgeries performed in Asian countries such as China and India will contribute to expanding the inhalation anesthetics market in Asia Pacific during the forecast period.
Some of the major players in the global Inhalation Anesthetics Market include Hikma Pharmaceuticals, Baxter International, Inc., AbbVie, Inc., Halocarbon Products Corporation, Piramal Healthcare, Mylan NV, Maruishi Pharmaceuticals Co. Ltd., Jiangsu Hengrui Medicine Co., Ltd., Neon Laboratories Ltd., Lunan Pharmaceuticals, andTroikaa Pharmaceuticals Ltd.
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Rest of Eastern Europe
> Asia Pacific
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...